Safety and immunogenicity of Ad26.COV2.S in adults: A randomised, double-blind, placebo-controlled Phase 2a dose-finding study. - Cárdenas V; Le Gars M; Truyers C; Ruiz-Guiñazú J; Struyf F; Colfer A; Bonten M; Borobia A; Reisinger EC; Kamerling IMC; Douoguih M; Sadoff J (Vaccine, 2024)